Assembly Biosciences, Inc.

États‑Unis d’Amérique

 
Quantité totale PI 68
Rang # Quantité totale PI 19 742
Note d'activité PI 2,7/5.0    76
Rang # Activité PI 9 230
Symbole boursier
ISIN US9228221019
Capitalisation 102M  (USD)
Industrie Biotechnology
Secteur Healthcare

Brevets

Marques

16 0
8 0
44 0
0
 
Dernier brevet 2024 - Oral pharmaceutical compositions
Premier brevet 2015 - Hepatitis b core protein alloste...

Derniers inventions, produits et services

2024 Invention Oral pharmaceutical compositions. The present invention relates to methods and compositions for t...
Invention Benzothia(dia)zepine compounds for treatment of hbv and hdv. The present disclosure provides, in ...
2023 Invention Hepatitis b core protein modulators. The present disclosure provides, in part, compounds having ...
Invention Bicyclic heterocycle compounds for treatment of herpes viruses. The present disclosure provides, ...
Invention Pharmaceutical compositions for herpes virus. The present invention relates to methods and compos...
Invention Cyclic urea thiazolyl compounds for treatment of hsv. The present disclosure provides, in part, c...
Invention A novel crystalline form of pritelivir. The invention relates to a novel crystalline form of prit...
Invention 2-(imidazo[1, 2-a]1,8-naphthyridin-8-yl)-1,3,4-oxadiazole derivatives as enhancers of innate immu...
2022 Invention Pharmaceutical compositions for the treatment of hbv. The present invention relates pharmaceutica...
Invention Crystalline forms of a 5-aminopyrazole compound useful for treating hbv. The present disclosure p...
Invention 5-membered heteroaryl carboxamide compounds for treatment of hbv. The present disclosure provides...
Invention Novel crystalline forms. The present disclosure generally relates to novel crystalline forms of a...
Invention Process. The present disclosure generally relates to methods of synthesizing compounds useful as ...
2021 Invention Pyrazole carboxamide compounds for treatment of hbv. The present disclosure provides, in part, p...
Invention 5-membered heteroaryl carboxamide compounds for treatment of hbv. The present disclosure provide...
Invention Pyrazole carboxamide compounds for treatment of hbv. The present disclosure provides, in part, py...
Invention Hepatitis b core protein allosteric modulators. The present disclosure provides, in part, compou...
Invention Cyclic sulfamide compounds and methods of using same. The present disclosure provides, in part, ...
Invention Process for making hepatitis b core protein modulators. The present disclosure provides, in part...
Invention Hepatitis b core protein modulators. The present disclosure provides, in part, compounds having a...
2020 Invention Compositions comprising bacterial species and methods related thereto. Alistipes, e.g.Alistipes s...
Invention Compositions comprising bacterial species and methods related thereto. The disclosure relates gen...
Invention Compositions comprising bacterial species and methods related thereto. Collinsella, e.g.,Collinse...
Invention Compositions comprising bacterial species and methods related thereto. Anaerostipese.g.Anaerostip...
Invention Compositions comprising bacterial species and methods related thereto. Catenibacterium, e.g.,Cate...
Invention Pharmaceutical compositions and methods for treating hbv disorders. Provided herein are methods o...
Invention Compositions comprising bacterial species and methods related thereto. Christensenella, e.g., Chr...
Invention Pharmaceutical compositions for the treatment of hbv. The present disclosure provides, in part, ...
Invention Pharmaceutical compositions for the treatment of hbv. The present disclosure provides, in part, p...
2019 Invention Cyclic sulfamide compounds for treatment of hbv. The present disclosure provides, in part, cycli...
2018 Invention Cyclic sulfamide compounds and methods of using same. The present disclosure provides, in part, c...